229 filings
ARS
2023 FY
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Annual report to shareholders
7:10am
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
DEF 14A
SYRS
Syros Pharmaceuticals Inc.
Definitive proxy
23 Apr 24
7:01am
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
S-8
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
8-K
qluqevjtvefd2beb 7n
8 Jan 24
Regulation FD Disclosure
7:06am
8-K
hc1hp7xew4p h5
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
lt65ae jd2pfi
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K
c671t9 hg35sh1tqr
6 Dec 23
Regulation FD Disclosure
7:05am
8-K
74nijy
2 Oct 23
Cost Associated with Exit or Disposal Activities
8:49am
8-K
p84mol
11 Aug 23
Termination of a Material Definitive Agreement
4:30pm
8-K
1oi4c tare6f
21 Jul 23
Termination of a Material Definitive Agreement
4:36pm
8-K
pgyiow0wzm11us
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
mhsy tkjhvvgowjqp3
25 May 23
Regulation FD Disclosure
5:10pm
424B5
c866fe4olod
1 May 23
Prospectus supplement for primary offering
4:06pm
EFFECT
mp6ywpevivhfm6qylvb0
1 May 23
Notice of effectiveness
12:15am